Idiopathic Short Stature: Diagnostic and Therapeutic Approach


Primary short stature—Skeletal abnormalities

With recognizable skeletal dysplasia (achondroplasia, hypochondroplasia)

Without recognizable skeletal dysplasia (Turner syndrome, SHOX gene haploinsufficiency)

Secondary short stature

Malnutrition

Psychosocial deprivation

Chronic diseases

Renal (renal failure, tubular acidosis, nephrotic syndrome)

Intestinal (celiac disease, intestinal inflammatory disease)

Hematological (chronic anemia)

Cardiac

Pulmonary (cystic fibrosis)

Endocrine

Hipothyroidism

Disorders of the GH/IGF-1 axis

Cushing’s syndrome

Pseudohipoparathyroidism

Rickets

Short stature without recognizable cause

Intrauterine growth retardation without recognizable cause (small for gestational age with failure of catch-up growth)

Idiopathic short stature

Familial short stature

Constitutional delay of growth and puberty


GH growth hormone, IGF-1 insulin-like growth factor type 1




Table 16.2
Disorders of the GH/IGF-1 axis

















































GH deficiency

Idiopathic

Acquired (craniopharyngioma, pituitary tumors, autoimmune diseases, granulomatous diseases, central nervous system infections, head trauma)

Genetic

GH secretion (GH1 and GHRHR genes)

Pituitary cells differentiation (POU1F1 and PROP1 genes)

Pituitary development (HESX1, GLI2, LHX3, LHX4, and SOX3 genes)

Bioinactive GH

GH1 gene mutation

GHInsensitivity

Primary

Laron syndrome (GHR gene)

Associated to immunodisfunction (abnormalities of GH signal transduction, e.g., STAT5B gene defect)

Secondary or acquired (AntiGH antibodies, malnutrition, liver disorders, diabetes mellitus poorly controlled, uremia)

Ternary complex formation deficiency (IGF-1/IGFBP-3/ALS)

Acid-labile subunit deficiency (IGFALS gene)

IGF-1deficiency

IGF1 gene

Bioinactive IGF-1

IGF1 gene mutation

IGF-1 insensitivity

IGF1R defects and post receptor defects


GH growth hormone, IGF-1 insulin-like growth factor type 1, IGFBP-3 insulin-like growth factors binding protein 3, ALS acid-label subunit


Clinical evaluation starts with a detailed medical and family history and a thorough physical examination (Table 16.3). A keypoint is a detailed description of the child’s growth pattern, including the time when the growth deficit was first observed. Birth characteristics must be evaluated (gestation and delivery conditions or complications; gestational age, birth weight, length and head circumference). This information is important to distinguish short children in two groups by the onset of the growth impairment: short stature with prenatal or postnatal onset. Medical history must be investigated, with a focus in neuropsychomotor development, nutritional status, medication use, and cardiac, renal, pulmonary and gastrointestinal diseases. Evaluation of a child’s height must take into account the familial patterns of growth and puberty [1].


Table 16.3
Specific diagnostic findings and keypoints in medical history and physical examination of children with short stature
































































Findings and keypoints

Interpretation and application

Medical History
 

Birth length, weight, head circumference, gestational age

Classification as SGA or AGA

Previous growth data

Height velocity and growth pattern analysis

Age at start of pubertal signs

Early, normal, or delayed puberty

Previous diseases, surgeries, and medication use

Organic or iatrogenic causes

Medical history of the various systems

Search for chronic and systemic diseases

Feeding and nutrition history

As example, Silver–Russell and Prader–Willi syndromes can lead to feeding difficulties

Neuropsychomotor development delay and/or intellectual disability

Syndromes, chromosomal disorders, metabolic disorders

Consanguinity

Likelihood of recessive genetic disorders

Parental height (measured)

To estimate the target height

Parents’ age at the start of puberty

To assess likelihood of a familiar pattern of delayed puberty

Physical Examination
 

Length or height, weight, head circumference, sitting height, arm span, forearm length

Altered sitting height–height ratio is suggestive of skeletal dysplasia

Weight-for-height or BMI showing underweight

Weight more affected than height, low weight-for-height and low BMI are suggestive of malnutrition

Weight-for-height or BMI showing overweight or obesity

Hypothyroidism, Cushing’s syndrome, GH deficiency, pseudohypoparathyroidism

Dysmorphic features

Syndromes

Pubertal stage

Early, normal or delayed puberty

General physical exam

Search for chronic and systemic diseases


SGA small for gestational age, AGA adequate for gestational age, IUGR intrauterine growth retardation, BMI body mass index, GH growth hormone, IGF-1 insulin-like growth factor type 1, CNS central nervous system

Physical examination should be complete, including the description of anthropometric measurements, facial and body dysmorphic features, and any other clues for one of the many causes of short stature. In children younger than 2 years of age, supine length, weight, weight-for-length, and head circumference will be measured, and fontanelles as well as dentition should be evaluated. In older children, erect height, weight, body mass index (BMI), head circumference, arm span, and sitting height (SH) should be measured [1]. In the latter, the pubertal staging has to be evaluated, as determined by Marshall and Tanner criteria [6, 7]. Evaluation of a child’s height must be done in the context of normal standards for sex and age with the international data at hand. Such standards can be either cross-sectional (by calculation of height SDS) or longitudinal (by plotting in growth charts). Serial measurements with a minimum interval of 6 months are necessary to determine the height velocity. Because genetic factors are important determinants of growth and height, all children should be assessed considering siblings and parents. For that purpose, the parental target height is calculated and expressed as mentioned above. When a child’s growth pattern clearly deviates from that of parents and siblings, the possibility of an underlying pathology should be considered [3].

Many abnormal growth states are characterized by disproportionate growth, which is strongly suggestive of skeletal dysplasia. Therefore, body proportion measurements should be part of the evaluation of short stature. We recommend the use of sitting height: height ratio (SH:H) for age and sex, which can also be expressed in SDS, according to published standards. This ratio allows for the observation of body proportion changes throughout development. Children with short stature and an increased SH:H ratio for age and sex have a disproportional short stature caused by limb abnormalities, while children with short stature and a decreased SH:H ratio for age and sex have a disproportional short stature caused by axial segment abnormalities [1, 8] (Fig. 16.1).

A301516_1_En_16_Fig1_HTML.gif


Fig. 16.1
Diagnostic approach in children with short stature. SDS = standard deviation score; TH = target height; CGH = comparative genomic hybridization

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Mar 10, 2017 | Posted by in ENDOCRINOLOGY | Comments Off on Idiopathic Short Stature: Diagnostic and Therapeutic Approach

Full access? Get Clinical Tree

Get Clinical Tree app for offline access